These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 17557278

  • 1. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
    He QY, Zhu R, Lei T, Ng MY, Luk JM, Sham P, Lau GK, Chiu JF.
    J Cell Biochem; 2008 Feb 15; 103(3):740-52. PubMed ID: 17557278
    [Abstract] [Full Text] [Related]

  • 2. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X, Wang F, Li YG, Zhu GP, Zhang WM.
    J Exp Clin Cancer Res; 2007 Dec 15; 26(4):505-8. PubMed ID: 18365545
    [Abstract] [Full Text] [Related]

  • 3. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L.
    J Gastroenterol Hepatol; 2009 Jan 15; 24(1):55-62. PubMed ID: 18823443
    [Abstract] [Full Text] [Related]

  • 4. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH.
    Clin Cancer Res; 2008 Jan 15; 14(2):470-7. PubMed ID: 18223221
    [Abstract] [Full Text] [Related]

  • 5. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX, Zhang B, Yu JK, Liu J, Yang MQ, Zheng S.
    Chin Med J (Engl); 2005 Aug 05; 118(15):1278-84. PubMed ID: 16117882
    [Abstract] [Full Text] [Related]

  • 6. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX, Wang Q, Zhang ZM, Huang S, Yuan WP, Liu JY, Ban KC, Zhao YN.
    Cancer Lett; 2009 Jul 08; 279(2):163-70. PubMed ID: 19268439
    [Abstract] [Full Text] [Related]

  • 7. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis.
    Feng JT, Liu YK, Song HY, Dai Z, Qin LX, Almofti MR, Fang CY, Lu HJ, Yang PY, Tang ZY.
    Proteomics; 2005 Nov 08; 5(17):4581-8. PubMed ID: 16240287
    [Abstract] [Full Text] [Related]

  • 8. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP, Shen J, Li ZF, Yan L, Gu J.
    Cancer Invest; 2006 Dec 08; 24(8):747-53. PubMed ID: 17162557
    [Abstract] [Full Text] [Related]

  • 9. Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma with magnetic bead-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu T, Xue R, Huang X, Zhang D, Dong L, Wu H, Shen X.
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul 08; 43(7):542-50. PubMed ID: 21659380
    [Abstract] [Full Text] [Related]

  • 10. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.
    Paradis V, Degos F, Dargère D, Pham N, Belghiti J, Degott C, Janeau JL, Bezeaud A, Delforge D, Cubizolles M, Laurendeau I, Bedossa P.
    Hepatology; 2005 Jan 08; 41(1):40-7. PubMed ID: 15690480
    [Abstract] [Full Text] [Related]

  • 11. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
    Liao J, Zhang R, Qian H, Cao L, Zhang Y, Xu W, Li J, Wu M, Yin Z.
    Biochem Biophys Res Commun; 2012 Apr 06; 420(2):308-14. PubMed ID: 22425980
    [Abstract] [Full Text] [Related]

  • 12. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.
    Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Chen DS, Yu CY, Wen CL, Lu FJ, Chow LP.
    Proteomics; 2006 May 06; 6(9):2865-73. PubMed ID: 16586433
    [Abstract] [Full Text] [Related]

  • 13. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC.
    BMC Cancer; 2005 Jul 20; 5():83. PubMed ID: 16029516
    [Abstract] [Full Text] [Related]

  • 14. Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry coupled with an artificial neural network model for the diagnosis of hepatocellular carcinoma.
    Hu Q, Huang Y, Wang Z, Tao H, Liu J, Yan L, Wang K.
    Hepatogastroenterology; 2012 Sep 20; 59(118):1902-6. PubMed ID: 22193438
    [Abstract] [Full Text] [Related]

  • 15. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
    Sun S, Lee NP, Poon RT, Fan ST, He QY, Lau GK, Luk JM.
    Liver Int; 2007 Oct 20; 27(8):1021-38. PubMed ID: 17845530
    [Abstract] [Full Text] [Related]

  • 16. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L, Cheng L, Tao L, Jia X, Lu Y, Liao P.
    Acta Otolaryngol; 2006 Aug 20; 126(8):853-60. PubMed ID: 16846929
    [Abstract] [Full Text] [Related]

  • 17. Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system.
    Kanmura S, Uto H, Kusumoto K, Ishida Y, Hasuike S, Nagata K, Hayashi K, Ido A, Stuver SO, Tsubouchi H.
    Hepatology; 2007 Apr 20; 45(4):948-56. PubMed ID: 17393466
    [Abstract] [Full Text] [Related]

  • 18. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
    Wei YS, Zheng YH, Liang WB, Zhang JZ, Yang ZH, Lv ML, Jia J, Zhang L.
    Cancer; 2008 Feb 01; 112(3):544-51. PubMed ID: 18085639
    [Abstract] [Full Text] [Related]

  • 19. [Serum proteomic spectra of esophageal squamous cell carcinoma patients analyzed with IMAC3 protein chip].
    Liu CZ, Zhu PY, Shi MX, Liu JB, Liao P, Xiang CQ, Zhang YX, Wang WJ.
    Ai Zheng; 2008 Mar 01; 27(3):272-8. PubMed ID: 18334116
    [Abstract] [Full Text] [Related]

  • 20. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
    Xu WH, Chen YD, Hu Y, Yu JK, Wu XG, Jiang TJ, Zheng S, Zhang SZ.
    Zhonghua Zhong Liu Za Zhi; 2006 Oct 01; 28(10):753-7. PubMed ID: 17366787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.